AF
NKTR icon

Allworth Financial’s Nektar Therapeutics NKTR Stock Holding History

Allworth Financial’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.8K Buy
714
+33
+5% +$2.42K ﹤0.01% 2491
2026
Q1 		$49K Buy
681
+5
+0.7% +$285 ﹤0.01% 2343
2025
Q4 		$28.6K Hold
676
– – ﹤0.01% 2576
2025
Q3 		$38.5K Sell
676
-2,690
-80% -$89K ﹤0.01% 2287
2025
Q2 		$87K Buy
3,366
+2,690
+398% +$30.2K ﹤0.01% 1620
2025
Q1 		$7.49K Hold
676
– – ﹤0.01% 2560
2024
Q4 		$9.31K Hold
676
– – ﹤0.01% 2467
2024
Q3 		$13.2K Hold
676
– – ﹤0.01% 2137
2024
Q2 		$14.1K Buy
676
+16
+2% +$337 ﹤0.01% 2078
2024
Q1 		$9.25K Hold
660
– – ﹤0.01% 2146
2023
Q4 		$5.59K Buy
+660
New +$5K ﹤0.01% 2231
2022
Q4 		– Sell
-3
Closed – – 3135
2022
Q3 		$0 Buy
+3
New +$178 ﹤0.01% 2947
2022
Q2 		– Sell
-2
Closed – – 2654
2022
Q1 		$0 Sell
2
-18
-90% -$2.66K ﹤0.01% 2282
2021
Q4 		$4K Sell
20
-26
-57% -$5.64K ﹤0.01% 1606
2021
Q3 		$12K Buy
+46
New +$11.1K ﹤0.01% 1230
2019
Q1 		– Sell
-39
Closed -$19K – 1008
2018
Q4 		$19K Hold
39
– – ﹤0.01% 422
2018
Q3 		$36K Hold
39
– – ﹤0.01% 335
2018
Q2 		$28K Sell
39
-11
-22% -$12.7K ﹤0.01% 355
2018
Q1 		$80K Hold
50
– – 0.01% 198
2017
Q4 		$45K Hold
50
– – ﹤0.01% 261
2017
Q3 		$18K Buy
+50
New +$15.6K ﹤0.01% 381

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's NKTR Position: Q2 2026 in Review

Allworth Financial increased its Nektar Therapeutics (NKTR) stake by 4.8% in Q2 2026, buying an estimated $2.42K and bringing the position to 714 shares worth $49.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2491.

Allworth Financial first reported a position in NKTR in Q3 2017 and has held it in 21 quarters since. The position peaked at $87K in Q2 2025. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Allworth Financial held 714 shares of Nektar Therapeutics worth $49.8K as of Q2 2026.
  • Allworth Financial bought 33 Nektar Therapeutics shares in Q2 2026, an estimated $2.42K.
  • Nektar Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2491 holding.
  • Allworth Financial first reported a position in Nektar Therapeutics in Q3 2017 and has held it in 21 quarters since.
  • Allworth Financial's Nektar Therapeutics position peaked at $87K in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.